Submission of audited standalone and consolidated financial results for the quarter and year ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medi-Caps Limited reported mixed standalone results but significant deterioration on consolidated basis for FY2025-26. Standalone revenue declined to Rs 230.59 Lacs from Rs 241.66 Lacs (4.6% decline), though the company posted a small net profit of Rs 13.87 Lacs after tax write-backs. However, consolidated revenue collapsed to Rs 1,244.85 Lacs from Rs 2,547.71 Lacs (51% decline) due to unstable political conditions in the USA market. The consolidated entity recorded a net loss of Rs 303.75 Lacs compared to profit of Rs 57.10 Lacs in the previous year. Operating cash flow turned sharply negative at Rs 699.40 Lacs on consolidated basis. The company has two segments - Pharma division and Real Estate division. The auditors gave an unmodified (clean) opinion on both standalone and consolidated financial statements.
The company is facing severe financial stress with consolidated revenue halving and a large net loss. The sharp negative operating cash flow of Rs 702 Lacs is a major red flag for liquidity. Shareholders should be concerned about the USA market impact and the company's ability to return to profitability.